Skip to main content

Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI

Clinical Images
08/01/2008
Case Report. A 78-year-old woman who had undergone coronary artery bypass grafting eight years earlier presented with unstable angina. At coronary angiography, an aorto-ostial lesion was found in a saphenous vein graft to the right posterior...
Case Report. A 78-year-old woman who had undergone coronary artery bypass grafting eight years earlier presented with unstable angina. At coronary angiography, an aorto-ostial lesion was found in a saphenous vein graft to the right posterior...
Case Report. A 78-year-old woman...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
10/01/2015
Intermediate SVG lesions have high rates of progression. The purpose of this study was to examine the impact of extended-release niacin (ER-niacin) vs. placebo on intermediate saphenous vein graft (SVG) lesions.
Intermediate SVG lesions have high rates of progression. The purpose of this study was to examine the impact of extended-release niacin (ER-niacin) vs. placebo on intermediate saphenous vein graft (SVG) lesions.
Intermediate SVG lesions have...
10/01/2015
Journal of Invasive Cardiology
Original Contribution
03/15/2017
This study evaluates the contribution of chronic total occlusion (CTO)-related SYNTAX score (SS) to the overall SS for patients with CTO and compares the traditional SS to a simplified variant.
This study evaluates the contribution of chronic total occlusion (CTO)-related SYNTAX score (SS) to the overall SS for patients with CTO and compares the traditional SS to a simplified variant.
This study evaluates the...
03/15/2017
Journal of Invasive Cardiology
Original Contribution
09/01/2021
We assessed the clinical and procedural characteristics, technical success, procedural success, and in-hospital outcomes of 2314 patients who underwent CTO-PCI at 20 experienced centers between 2012 and 2017, classified according to whether...
We assessed the clinical and procedural characteristics, technical success, procedural success, and in-hospital outcomes of 2314 patients who underwent CTO-PCI at 20 experienced centers between 2012 and 2017, classified according to whether...
We assessed the clinical and...
09/01/2021
Journal of Invasive Cardiology
Letter from the Editor
08/27/2019
CTO-PCI often requires administration of large contrast volume. The DyeVert system (Osprey Medical, Inc) is a device that interfaces with standard manifold systems to reduce the amount of contrast used. We compared the procedural outcomes of...
CTO-PCI often requires administration of large contrast volume. The DyeVert system (Osprey Medical, Inc) is a device that interfaces with standard manifold systems to reduce the amount of contrast used. We compared the procedural outcomes of...
CTO-PCI often requires...
08/27/2019
Journal of Invasive Cardiology
Vascular Disease
08/05/2014
Crossing of lower-extremity arterial chronic total occlusion (CTO) can be challenging. This study examines the use of the Viance peripheral CTO crossing device (Covidien) in the superficial femoral, popliteal, and below-the knee arterial...
Crossing of lower-extremity arterial chronic total occlusion (CTO) can be challenging. This study examines the use of the Viance peripheral CTO crossing device (Covidien) in the superficial femoral, popliteal, and below-the knee arterial...
Crossing of lower-extremity...
08/05/2014
Journal of Invasive Cardiology
Original Contribution
05/27/2016
The use of SVGs for retrograde native vessel CTO-PCI has received limited study. We reviewed the medical records and coronary angiograms of retrograde CTO-PCIs performed through an SVG at 4 U.S. institutions between 2012 and 2013.
The use of SVGs for retrograde native vessel CTO-PCI has received limited study. We reviewed the medical records and coronary angiograms of retrograde CTO-PCIs performed through an SVG at 4 U.S. institutions between 2012 and 2013.
The use of SVGs for retrograde...
05/27/2016
Journal of Invasive Cardiology
Review
04/01/2023
Journal of Invasive Cardiology
Commentary
12/04/2009
Atheroemboli during percutaneous peripheral arterial interventions (PAI) complicate about 1–2% of procedures, with serious adverse outcomes, although their true incidence is estimated to be much greater.1 In the era of increasing number and...
Atheroemboli during percutaneous peripheral arterial interventions (PAI) complicate about 1–2% of procedures, with serious adverse outcomes, although their true incidence is estimated to be much greater.1 In the era of increasing number and...
Atheroemboli during percutaneous...
12/04/2009
Journal of Invasive Cardiology